Cat. #154132
CHEC-7 immunomodulatory Peptide
Cat. #: 154132
Availability: Please enquire for quantities and pricing
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Timothy Cunningham
Institute: Drexel University
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Tool name: CHEC-7 immunomodulatory Peptide
- Alternate name: Human neuroprotective polypeptide Diffusible Survival Evasion Peptide (DSEP)
- Research fields: Immunology;Neurobiology
- Sequence: CHEASQC
- Description: The CHEC-7 (peptide sequence CHEASQC) peptide is modified from immunomodulatory CHEC-9 peptide by eliminating two central alanines followed by cyclization to be a more potent uncompetitive sPLA2 inhibitor. The neuroprotective/anti-inflammatory cyclic heptapeptide, CHEC-7, stimulates HSP70's disaggregase activity and is used in the study of protein aggregate disease, including age-related failures of protein repair like Alzheimerâs Disease. The peptide also showed promising results in treating Autoimmune Myeloencephalitis tested in a rat model.
Handling
- Shipping conditions: Dry Ice
References
- Cunningham et al. 2018. Rejuvenation Res. 21(6):527-534. PMID: 29651925.
- Heptamer Peptide Disassembles Native Amyloid in Human Plasma Through Heat Shock Protein 70.
- Uncompetitive Phospholipase A2 Inhibition by CHEC Sequences Including Oral Treatment of Experimental Autoimmune Myeloencephalitis
